Omontys (peginesatide) – for Treatment of Anaemia Associated with Chronic Kidney Disease

Omontys (peginesatide) is an erythropoiesis-stimulating agent (ESA) developed for the treatment of anaemia associated with chronic kidney disease (CKD).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news